BusinessPreclinical Data Showing Synergy of Biothera Pharmaceuticals’ Imprime PGG and a CD40 Agonist in a Pancreatic Cancer Model Presented at Keystone SymposiaBy Nasdaq OMXMar 26, 2018, 2:00 PM UTC
BusinessBiothera Pharmaceuticals Presents Data Broadening Imprime PGG Mechanism of ActionBy Nasdaq OMXNov 13, 2017, 2:30 PM UTC
BusinessBiothera Pharmaceuticals Presents Preclinical Data Showing Imprime PGG Activates Natural Killer Cell-Mediated Tumor KillingBy Nasdaq OMXOct 30, 2017, 1:01 PM UTC
BusinessBiothera Announces Three Presentations at Upcoming American Association for Cancer Research (AACR) Annual MeetingBy Nasdaq OMXMar 27, 2017, 3:00 PM UTC
